Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Cancer Chemotherapy and Pharmacology|January 1, 1996
A single-sample assay for the estimation of the area under the free carboplatin plasma concentration versus time curveS Ghazal-Aswad, A H Calvert, D R NewellSingapore Medical Journal|November 29, 2007
Primary umbilical adenocarcinomaK A Y Alnaqbi, S Joshi, S Ghazal-Aswad, et al.The Journal of Family Planning and Reproductive Health Care|November 30, 2002
Knowledge and practice of contraception in United Arab Emirates womenS Ghazal-Aswad, D E Rizk, S M Al-Khoori, et al.International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|February 5, 2003
Factors influencing the quality of life of infertile women in United Arab EmiratesG M Khayata, D E E Rizk, M Y Hasan, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 4, 1999
Pharmacokinetically guided dose escalation of carboplatin in epithelial ovarian cancer: effect on drug-plasma AUC and peripheral blood drug-DNA adduct levelsS Ghazal-Aswad, M J Tilby, M Lind, et al.British Journal of Cancer|August 1, 1996
The relationship between tumour glutathione concentration, glutathione S-transferase isoenzyme expression and response to single agent carboplatin in epithelial ovarian cancer patientsS Ghazal-Aswad, L Hogarth, A G Hall, et al.Seminars in Oncology|October 1, 1994
Carboplatin and granulocyte colony-stimulating factor as first-line treatment for epithelial ovarian cancer: a phase I dose-intensity escalation studyA H Calvert, M J Lind, S Ghazal-Aswad, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
Phase I study of pharmacologically based dosing of carboplatin with filgrastim support in women with epithelial ovarian cancerM J Lind, S Ghazal-Aswad, L Gumbrell, et al.Pageof 1